FDA approves over-the-counter hearing aids, no exams required
By
Alicia Lasek
Aug 17, 2022
The Food and Drug Administration has established a new category of over-the-counter hearing aids that don’t require oversight by audiologists for purchase, according to a final rule announced Tuesday.
Blinking lights and deadly bacteria
By
Gary Tetz
Dec 19, 2013
Well, alrighty then. Looks like I didn’t win the lottery. So I guess I’ll have to buckle down and write yet another profound but cheeky blog post for this fine long-term care news magazine....
COVID shot boosters for all adults will help to reduce confusion, FDA says
By
Alicia Lasek
Nov 22, 2021
The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Group re-assessing antipsychotic label warning
By
Kristen Fischer
Mar 22, 2024
Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults.
FDA advisers vote unanimously to endorse Novavax’s COVID-19 vaccine
By
Alicia Lasek (f3)
Jun 08, 2022
Independent advisers have voted 21 to 0 to recommend the authorization of Novavax’s COVID-19 protein-based vaccine for pandemic emergency use.
FDA calls for investigation into its approval of controversial Alzheimer’s drug
By
Alicia Lasek
Jul 12, 2021
The acting chief of the Food and Drug Administration has called for an investigation into the events leading up to the approval of Biogen’s brain plaque-clearing dementia drug aducanumab (Aduhelm).
CDC chief endorses COVID booster shots for nursing home residents, healthcare workers
By
Alicia Lasek
Sep 24, 2021
Older and medically compromised adults and workers in high-risk settings should be offered third doses of the Pfizer-BioNTech vaccine, CDC Director Rochelle Walensky, M.D., said early Friday. Her decision...
CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.
A first: FDA approves drug to treat agitation in Alzheimer’s dementia
By
Alicia Lasek
May 12, 2023
For the first time, the FDA has approved a drug to treat agitation related to Alzheimer’s disease dementia. Patient advocates are hailing the news, but prescribing the drug, an antipsychotic, may put...